Niagen Bioscience, Inc. (NAGE) — Cash Flow Quality Index
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Quality Index of 0.81x as of September 2025. Operating cash flow of $3.69 Million is below net income of $4.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Niagen Bioscience, Inc. asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Niagen Bioscience, Inc. Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Niagen Bioscience, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NAGE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Niagen Bioscience, Inc. (2024–2024)
Year-by-year earnings quality comparison for Niagen Bioscience, Inc.. For live market cap and the full company financial profile, see Niagen Bioscience, Inc. stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.42x | $12.11 Million | $8.55 Million | — |